Home/Filings/4/A/0001179110-21-003876
4/A//SEC Filing

Schwartz Carl I. 4/A

Accession 0001179110-21-003876

CIK 0001446159other

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 5:09 PM ET

Size

5.6 KB

Accession

0001179110-21-003876

Insider Transaction Report

Form 4/AAmended
Period: 2021-02-24
Transactions
  • Award

    Common Stock

    2021-02-24$1.43/sh+100,401$143,5731,711,742 total
Footnotes (2)
  • [F1]On April 21, 2020, the reporting person exchanged an outstanding promissory note of the issuer for shares of common stock at $1.43 per share pursuant to an exchange agreement. The parties subsequently discovered a calculation error under which an additional $143,574 in interest should have been included in the balance of the exchanged note as of April 21, 2020, and the additional shares reported herein were issued on account of such additional interest.
  • [F2]This form is being amended to correct the transaction code to an "A" to reflect that the transaction between the Issuer and Officer (at the time) is exempt under Rule 16b-3(d).

Documents

1 file

Issuer

Predictive Oncology Inc.

CIK 0001446159

Entity typeother

Related Parties

1
  • filerCIK 0001573354

Filing Metadata

Form type
4/A
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 5:09 PM ET
Size
5.6 KB